| Name | Bio | ||
|---|---|---|---|
| Peter Barrett | Peter Barrett is a partner and focuses on investments in therapeutics and medical technologies that significantly change the medical management of patients. At Atlas Venture, Peter has been involved in the creation of several novel therapeutic and d show more… | ||
| Nessan Bermingham | show more… | ||
| Kevin Bitterman | Bitterman joins Atlas after a successful tenure with Polaris Partners. Over the past decade, Bitterman was the founding CEO of Editas Medicine (NASDAQ: EDIT), Morphic Therapeutic and Visterra and co-founded Genocea Biosciences (NASDAQ: GNCA). He was show more… | ||
| Bruce Booth | Bruce Booth is a partner and focuses on novel biopharmaceutical products, therapeutic platforms, and innovative biomedical technologies. Bruce has been instrumental in forming unique, innovative, and capital efficient structures for drug discovery a show more… | @LifeSciVC | |
| Bruce Booth | Bruce is a partner at Atlas Venture where he focuses on novel biopharmaceutical products, therapeutic platforms, and innovative biomedical technologies. He is currently chairman AvroBio, mirage Therapeutics, Nimbus Therapeutics, Rodin Therapeutics an show more… |
